Back to Search
RICHARD MCLENDON, M.D.
M.D.
Anatomic Pathology & Clinical Pathology Physician
NPI: 1265416200Individual
Specialties, Licenses & Credentials
Anatomic Pathology & Clinical Pathology PhysicianPrimary
Pathology — Anatomic Pathology & Clinical Pathology
Code: 207ZP0102X
011132(TN)
Research & Publications (20)
Phase 2 trial of erlotinib plus sirolimus in adults with recurrent glioblastoma.
PMID 19562254·J Neurooncol·2010
3-trial
Treatment of HER2-positive breast carcinomatous meningitis with intrathecal administration of alpha-particle-emitting (211)At-labeled trastuzumab.
PMID 19647172·Nucl Med Biol·2009
7-preclinical
Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma.
PMID 19204199·J Clin Oncol·2009
3-trial
Phase I trial of temozolomide plus O6-benzylguanine 5-day regimen with recurrent malignant glioma.
PMID 19289491·Neuro Oncol·2009
3-trial
Targeting interleukin 6 signaling suppresses glioma stem cell survival and tumor growth.
PMID 19658188·Stem Cells·2009
7-preclinical
Few isolated neurons in hypothalamic hamartomas may cause gelastic seizures.
PMID 19521137·Pediatr Neurosurg·2009
5-case
Phase II trial of Gliadel plus O6-benzylguanine in adults with recurrent glioblastoma multiforme.
PMID 19188181·Clin Cancer Res·2009
3-trial
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.
PMID 19477429·Cancer Cell·2009
7-preclinical
Phase II trial of temozolomide (TMZ) plus irinotecan (CPT-11) in adults with newly diagnosed glioblastoma multiforme before radiotherapy.
PMID 19533023·J Neurooncol·2009
3-trial
Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma.
PMID 19185848·Cancer Cell·2009
7-preclinical
Phase 1 trial of temozolomide plus irinotecan plus O6-benzylguanine in adults with recurrent malignant glioma.
PMID 19402172·Cancer·2009
3-trial
Chordoid glioma: a case report and molecular characterization of five cases.
PMID 18652591·Brain Pathol·2009
5-case
Brain cancer stem cells display preferential sensitivity to Akt inhibition.
PMID 18802038·Stem Cells·2008
7-preclinical
Efficacy of high-dose chemotherapy or standard salvage therapy in patients with recurrent medulloblastoma.
PMID 18755919·Neuro Oncol·2008
8-other
Targeting cancer stem cells through L1CAM suppresses glioma growth.
PMID 18676824·Cancer Res·2008
7-preclinical
Mismatch repair deficiency does not mediate clinical resistance to temozolomide in malignant glioma.
PMID 18676759·Clin Cancer Res·2008
8-other
Splenda alters gut microflora and increases intestinal p-glycoprotein and cytochrome p-450 in male rats.
PMID 18800291·J Toxicol Environ Health A·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1211 UNION AVE, SUITE 300
MEMPHIS, TN 38104 - Phone
- (901) 725-7551
Quick Facts
- NPI
- 1265416200
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile